Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Widdop

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|January 12, 2026
Investigational insights into the potential of angiotensin type II receptor agonists as therapeutics for idiopathic pulmonary fibrosisOlivia N Young, Robert E Widdop, Jane E Bourke
Experimental Physiology|November 16, 2004
Differential cardiovascular responses to stressors in hypertensive and normotensive ratsStuart J McDougall, Andrew J Lawrence, Robert E Widdop
Autonomic Neuroscience : Basic & Clinical|November 18, 2005
Central autonomic integration of psychological stressors: focus on cardiovascular modulationStuart J McDougall, Robert E Widdop, Andrew J Lawrence
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Sex-differences in circadian blood pressure variations in response to chronic angiotensin II infusion in ratsAmanda K Sampson, Robert E Widdop, Kate M Denton
British Journal of Pharmacology|October 8, 2003
Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxideRuth E Hannan, Elizabeth A Davis, Robert E Widdop
American Journal of Physiology. Heart and Circulatory Physiology|December 24, 2004
AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive ratsLisa M Duke, Roger G Evans, Robert E Widdop
Hypertension (Dallas, Tex. : 1979)|March 16, 2005
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious ratsPia E Walters, Tracey A Gaspari, Robert E Widdop
Journal of Molecular and Cellular Cardiology|November 4, 2004
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockadeEmma S Jones, M Jane Black, Robert E Widdop
International Journal of Hypertension|April 14, 2012
Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) BlockadeEmma S Jones, M Jane Black, Robert E Widdop
British Journal of Pharmacology|December 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosisChrishan S Samuel, Yifang Li, Yan Wang, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|January 12, 2026
Investigational insights into the potential of angiotensin type II receptor agonists as therapeutics for idiopathic pulmonary fibrosisOlivia N Young, Robert E Widdop, Jane E Bourke
Experimental Physiology|November 16, 2004
Differential cardiovascular responses to stressors in hypertensive and normotensive ratsStuart J McDougall, Andrew J Lawrence, Robert E Widdop
Autonomic Neuroscience : Basic & Clinical|November 18, 2005
Central autonomic integration of psychological stressors: focus on cardiovascular modulationStuart J McDougall, Robert E Widdop, Andrew J Lawrence
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Sex-differences in circadian blood pressure variations in response to chronic angiotensin II infusion in ratsAmanda K Sampson, Robert E Widdop, Kate M Denton
British Journal of Pharmacology|October 8, 2003
Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxideRuth E Hannan, Elizabeth A Davis, Robert E Widdop
American Journal of Physiology. Heart and Circulatory Physiology|December 24, 2004
AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive ratsLisa M Duke, Roger G Evans, Robert E Widdop
Hypertension (Dallas, Tex. : 1979)|March 16, 2005
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious ratsPia E Walters, Tracey A Gaspari, Robert E Widdop
Journal of Molecular and Cellular Cardiology|November 4, 2004
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockadeEmma S Jones, M Jane Black, Robert E Widdop
International Journal of Hypertension|April 14, 2012
Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) BlockadeEmma S Jones, M Jane Black, Robert E Widdop
British Journal of Pharmacology|December 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosisChrishan S Samuel, Yifang Li, Yan Wang, et al.
Pageof 12